Panicker Shirly G, Mandal Anil K, Reddy Aramati B M, Gothwal Vijaya K, Hasnain Seyed E
Kallam Anji Reddy Molecular Genetics Laboratory, Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, Hyderabad, India.
Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1149-56. doi: 10.1167/iovs.03-0404.
To establish the genotype-phenotype correlations of various CYP1B1 (human cytochrome P450) mutations in patients in India with primary congenital glaucoma (PCG).
The study cohort comprised 146 patients with PCG from 138 pedigrees. Patients were analyzed for six distinct CYP1B1 mutations by sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods. A severity index for grading various PCG phenotypes was constructed based on clinical parameters.
Six mutations were identified in 45 patients analyzed and genotype-phenotype correlations were established for 43 of them. The percentages of severe phenotypes associated with various mutations in at least one eye were: frameshift, 100%; G61E, 66.7%; P193L, 62.5%; E229K, 80%; R368H, 72%; R390C, 83.3%. The frameshift mutation resulted in blindness. Based on the severity index, the disease severity was graded from normal to severe and the prognosis from good to very poor (blind). De novo mutation was identified in one family.
This is the first study to attempt to devise a severity index for grading various PCG phenotypes and to use genotype as an indicator to predict the prognoses of the disorder. This index may help guide therapy and counseling of the afflicted family regarding the progression of the disorder. All patients with severe phenotypes showed poor prognoses (r = 0.976; P < 0.0001). The data derived from this study could be used as an added clinical tool in disease management. Integrated management of PCG that makes use of a genetic approach could yield better results than medical, surgical, and rehabilitation interventions alone.
建立印度原发性先天性青光眼(PCG)患者中各种CYP1B1(人细胞色素P450)突变的基因型-表型相关性。
研究队列包括来自138个家系的146例PCG患者。通过测序和聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法分析患者的6种不同CYP1B1突变。基于临床参数构建了用于对各种PCG表型进行分级的严重程度指数。
在分析的45例患者中鉴定出6种突变,并为其中43例建立了基因型-表型相关性。至少一只眼中与各种突变相关的严重表型的百分比分别为:移码突变,100%;G61E,66.7%;P193L,62.5%;E229K,80%;R368H,72%;R390C,83.3%。移码突变导致失明。根据严重程度指数,疾病严重程度从正常到严重分级,预后从良好到极差(失明)。在一个家族中鉴定出新生突变。
这是第一项尝试设计用于对各种PCG表型进行分级的严重程度指数并将基因型用作预测该疾病预后指标的研究。该指数可能有助于指导对患病家庭进行疾病进展方面的治疗和咨询。所有具有严重表型的患者预后均较差(r = 0.976;P < 0.0001)。本研究获得的数据可作为疾病管理中的一种额外临床工具。采用遗传方法的PCG综合管理可能比单独的药物、手术和康复干预产生更好的效果。